In the outcome of changes in the total cholesterol levels, low credibility of ICEMAN result shows that L-carnitine supplementation has no difference in changes in NAFLD/duration_12 weeks (MD: 2.5, 95%CI: 14.85 to 9.81) but has significant changes (reduced) in the NASH/duration_24 weeks (MD: 20.7, 95%CI: 28.22 to 13.22)
Current therapeutic uses for CJC-1295 and ipamorelin Like sermorelin, another growth hormone secretagogue, CJC-1295 and ipamorelin are non-FDA-approved medications whose therapeutic uses are entirely off-label
In addition, the data indicate that the effect is folate receptor mediated because EC 1496 (trace (d)) is also significantly different from the competition control group where EC1496 is co-administered with excess folic acid (trace (d))
Some compounding pharmacies have pivoted to emphasizing the "clinically meaningful difference" angle, arguing that the addition of levocarnitine makes their product sufficiently different from commercial Mounjaro/Zepbound to justify continued compounding
Bring all medication and supplement containers to your appointments so your healthcare provider can review them
